A key feature of the partnership is the NYSF Year 12 Program; a 12-day residential program designed to give students a broader understanding of the diverse study and career options available in science, technology, engineering and mathematics (STEM) and to encourage continued studies in these fields.
Under the agreement, CSL scientists participate in the summer program, sharing their career insights and learnings with aspiring young scientists.
The announcement follows delivery of the 2019 residential program in January, reaching 600 students representing every state and territory of Australia. Over 12,000 young people have participated in the program since it began in 1984, including many influential Australian scientists.
CSL’s Chief Scientific Officer, Professor Andrew Cuthbertson said, “As Australia’s largest biotechnology company, CSL is committed to fostering the next generation of biomedical researchers. Our partnership with the NYSF spans 10 years and we are very proud to continue our support for this valuable program.”
“It is vitally important for Australia’s future prosperity that more students pursue careers in STEM. Programs like the NYSF play an important role in expanding students’ career horizons and igniting their passion for science. Our scientists are very committed to supporting the program and really enjoy their interactions with program participants.”
NYSF Chief Executive Officer, Dr Damien Pearce, said the partnership allows the NYSF to continue to deliver high quality STEM outreach programs for Australian youth.
“We welcome CSL’s continued investment which reflects their commitment to the valuable role of outreach and extension programs to encourage young Australians to continue studies in the areas of science, technology and engineering,” Dr Pearce said.
“The NYSF is a mature and unique program that mixes science related activities with personal development and early career professional networking. Thirty-five years on we know that coming to the NYSF has a positive impact on participants and increases their understanding of what may be possible after year 12, and how studying science, technology, engineering and mathematics can lead to an interesting and fulfilling career.”
Ayoka Wong, from Townsville, attended the NYSF 2018 program and returned in 2019 as a student staff leader.
Commenting on her experience, Ms Wong said, “As a student who is interested in a STEM career, and especially medicine, it is great to see that there are companies interested in helping younger people understand how they can develop into scientists who work in these fields. Learning about the jobs available in companies like CSL shows us what we might be able to do in the future. It’s important to note, that as students, we really do appreciate their support and guidance.”
- ends -
CSL Media Contact
Christina Hickie, Phone: +61 9389 3425/ 0429 609 762
CSL (ASX:CSL) is a leading global biotechnology company with a dynamic portfolio of life-saving medicines, including those that treat haemophilia and immune deficiencies, as well as vaccines to prevent influenza. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL — including our two businesses, CSL Behring and Seqirus - provides life-saving products to more than 60 countries and employs 22,000 people. Our unique combination of commercial strength, R&D focus and operational excellence enables us to identify, develop and deliver innovations so our patients can live life to the fullest. For more information about CSL Limited, visit www.csl.com